JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats

European Journal of Pharmacology

Volumn 367, Issue 1, 1999, Pages 91-99

  Ohta, Takeshi ^a   Furukawa, Noboru ^a   Yonemori, Fumihiko ^a   Wakitani, Korekiyo ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Anti hyperglycemic effect; Insulin secretion; JTT 608; Streptozotocin

Indexed keywords

4 (4 METHYLCYCLOHEXYL) 4 OXOBUTYRIC ACID; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCOSE; INSULIN; STREPTOZOCIN; TOLBUTAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN RELEASE; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; BUTYRIC ACIDS; CYCLOHEXANES; DIABETES MELLITUS, EXPERIMENTAL; FASTING; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYBURIDE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TOLBUTAMIDE;

EID: 0033042904     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00952-2     Document Type: Article

References (24)

1. Asplund K., Wiholm B.E., Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia. 24:1983;412-417.
2. Dunbar J.C., Foá P.P. An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals. Diabetologia. 10:1974;27-35.
3. Efendic S., Cerasi E., Luft R., Gladnikkoff G. Potentiation of glucose-induced insulin release by glucose in the isolated pancreas of fed and fasted rats. Diabetes. 25:1976;949-954.
4. Ferner R.E., Neil H.A.W. Sulphonylureas and hypoglycaemia. Br. Med. J. 296:1988;949-950.
5. Filipponi P., Marcelli M., Nicoletti I., Pacifici R., Santeusanio F., Brunetti P. Suppressive effect of long term sulfonylurea treatment on A, B, and D cells of normal rat pancreas. Endocrinology. 113:1983;1972-1979.
6. Firth R.G., Bell P.M., Marsh H.M., Hansen I., Rizza R.A. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. J. Clin. Invest. 77:1986;1525-1532.
7. Gerich J.E. Oral hypoglycemic agents. N. Engl. J. Med. 321:1989;1231-1245.
8. Giroix M.-H., Portha B., Kergoat M., Bailbe D., Picon L. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. Diabetes. 32:1983;445-451.
9. Groop L.C. Sulfonylureas in NIDDM. Diabetes Care. 15:1992;737-754.
10. Jackson J.E., Bressler R. Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1. Drugs. 22:1981;211-245.
11. Kawai K., Suzuki S., Murayama Y., Watanabe Y., Yamashita K. Comparison of B-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats. Diabetes Res. Clin. Pract. 12:1991;163-172.
12. Kelley D., Mokan M., Veneman T. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus. Metabolism. 43:1994;1549-1557.
13. Kosaka K., Kuzuya T., Hagura R. Insulin secretory response in Japanese type 2 (non-insulin-dependent) diabetic patients. Diabetes Res. Clin. Pract. 24:1994;S101-S110.
14. Ligtenberg J.J.M., Venker C.E., Sluiter W.J., Reitsma W.D., Van Haeften T.W. Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man. Eur. J. Clin. Invest. 27:1997;685-689.
15. Perley M.J., Kipnis D.M. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J. Clin. Invest. 46:1967;1954-1962.
16. Pfeifer M.A., Halter J.B., Porte D. Insulin secretion in diabetes mellitus. Am. J. Med. 70:1981;579-588.
17. Polonsky K.S., Given B.D., Hirsch L.J., Tillil H., Shapiro E.T., Beebe C., Frank B.H., Galloway J.A., Cauter E.V. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 318:1988;1231-1239.
18. Porte D. β-cells in type II diabetes mellitus. Diabetes. 40:1991;166-180.
19. Portha B., Levacher C., Picon L., Rosselin G. Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes. 23:1974;889-895.
20. Portha B., Blondel O., Serradas P., McEvoy R., Giroix M.-H., Kergoat M., Bailbe D. The rat models of non-insulin dependent diabetes induced by neonatal streptozotocin. Diabetes Metab. 15:1989;61-75.
21. Portha B., Serradas P., Bailbé D., Suzuki K., Goto Y., Giroix M.-H. β-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes. 40:1991;486-491.
22. Sodoyez J.C., Sodoyez-Goffaux F., Dunbar J.C., Foa P.P. Reduction in the activity of the pancreatic islets induced in normal rodents by prolonged treatment with derivatives of sulfonylurea. Diabetes. 19:1970;603-609.
23. Taylor S.I., Accili D., Imai Y. Insulin resistance or insulin deficiency. Diabetes. 43:1994;735-740.
24. Weir J.C., Clore E.T., Zmachinski C.J., Bonner-weir S. Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes. 30:1981;590-595.